SCHEMBL24986906

SCHEMBL24986906

c1ccc(-c2ccc3c4ccccc4n(-c4ccc5c(c4)c4ccccc4n5-c4ccc5c6ccccc6n(-c6cccc([Si](c7ccccc7)(c7ccccc7)c7ccccc7)c6)c5c4)c3c2)cc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
ATM Q13315 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
RAC2 P15153 1/20 0.34
RAC3 P60763 1/20 0.34
CDC42 P60953 1/20 0.34
RAC1 P63000 1/20 0.34
TSPO P30536 1/20 0.33
HDAC4 P56524 1/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 2/20 0.33
MEN1 O00255 1/20 0.33
RXRA P19793 1/20 0.33
RXRB P28702 1/20 0.33
KHK P50053 2/20 0.32
EDNRB P24530 1/20 0.32
EDNRA P25101 1/20 0.32
OPRD1 P41143 1/20 0.32
NR3C1 P04150 1/20 0.32
AVPR1A P37288 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24988356 1.00 KDM4E (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24987660 1.00 KDM4E (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24986603 0.99 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24089304 0.99 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24987894 0.99 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24988358 0.98 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24986908 0.98 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24987663 0.98 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24987888 0.96 L3MBTL1 (0.41) KDM4EATML3MBTL1RAC2RAC3
SCHEMBL24987891 0.96 L3MBTL1 (0.44) KDM4EATML3MBTL1HDAC4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230019868-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230019868-A1 HETEROCYCLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING HETEROCYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING ORGANIC LIGHT-EMITTING DEVICE CYP1A1, AOX1, ODC1 KDM4E 3300/4885ATM 3528/4885L3MBTL1 950/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.